2024-10-19 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management services, and health services.

**1. Performance Comparison:**

* **Cumulative Return:** CVS has experienced a cumulative return of **-31.54%** compared to the S&P 500 (VOO) which has gained **136.97%**. This signifies a significant underperformance of CVS relative to the broader market. 
* **Relative Divergence:** CVS is currently **168.51%** below the S&P 500, representing a major divergence. This implies that CVS has significantly lagged behind the market in terms of performance.

**2. Recent Price Movements:**

* **Closing Price:** 63.67
* **5-day Moving Average:** 65.56
* **20-day Moving Average:** 62.93
* **60-day Moving Average:** 59.74

The recent price movements indicate a slight downtrend as the closing price is below the 5-day and 20-day moving averages. However, the stock is above the 60-day moving average, suggesting potential support.

**3. Technical Indicators:**

* **RSI:** 57.35 - This value suggests that the stock is in a neutral territory, neither overbought nor oversold.
* **PPO:** -0.1 - A negative value indicates that the stock is experiencing some downward momentum.
* **Delta_Previous_Relative_Divergence:** 0.0 -  This indicates that the current relative divergence trend is stable, neither showing signs of significant upward or downward momentum.
* **Expected Return:** 0.0 - The expected return is currently estimated at 0.0%, indicating no anticipated outperformance relative to the S&P 500 over the next 5 years.

**4. Recent Earnings and Outlook:**

| Date        | EPS     | Expected EPS |
|-------------|---------|-------------|
| 2024-08-07 | 1.83    | 1.73         |
| 2024-05-01 | 1.31    | 1.7          |
| 2024-02-07 | 2.12    | 2.01         |
| 2023-11-01 | 2.21    | 2.13         |
| 2023-08-02 | 2.21    | 2.12         |

CVS has consistently surpassed analysts' earnings expectations in recent quarters. The latest earnings report for the quarter ended August 7, 2024, showed EPS of $1.83, exceeding the estimated $1.73. This positive trend suggests that the company is performing well despite the challenging economic environment.

**5. News and Recent Issues:**

**Recent Market Outlook:** 

* CVS is facing various challenges, including rising inflation, labor shortages, and increased competition from other healthcare providers. 
* However, the company's strong brand recognition, extensive network of stores, and expanding health services portfolio present growth opportunities.

**Analyst Opinions:**

* Analysts remain cautiously optimistic about CVS's future performance, citing its dominant position in the pharmacy market and its efforts to diversify its business into health services. 
* Some analysts believe that CVS's share price is undervalued and has potential for upside growth. 

**Performance Highlights:**

* FINBOLD reports that CVS has successfully navigated the pandemic and demonstrated resilience in a volatile market. 
* CVS's strategic initiatives, including its investments in digital platforms and healthcare services, are anticipated to contribute to its long-term growth.

**6. Summary:**

CVS is currently underperforming the S&P 500, exhibiting a significant divergence in returns. However, the company's recent earnings performance has been positive, exceeding analysts' expectations. Despite facing challenges, CVS's strategic initiatives and market dominance provide potential for growth in the future. 

**7. Conclusion:**

CVS Health Corp presents a mixed outlook for investors. While the company has demonstrated resilience and strong earnings, its recent underperformance relative to the market remains a concern. Its strategic initiatives and market position offer potential for growth, but investors should carefully consider the challenges and risks involved. 
